The 1990 amendments to the Clean Air Act required the EPA to institute new pollution control technology requirements for industrial sources of air pollution. In part because agreement could not be reached on the best way for the EPA to determine whether any significant isks to human health will remain after the technology controls are in place, the amendments also created a Commission on Risk Assessment and Risk Management and gave the commission a broad mandate to review and make recommendations concerning risk aessment and risk management in federal regulatory progms. In its March 1997 final report to Congress and the administration, the commision recommended a tiered approach to assesing such residual risks. That approach induded the idea that when decisions about managing residual risks are made, emissions should be evaluated in the contest of other sources of air pollution. Evaluating residual risk assessment as well as a framework for environmental health risk management. The framework is intended to improve the logic, consistency, and acceptability of decisions related to public health protection and environmental risk management and has six components (see Fig. 1 A public health approach to risk management emphasizes prevention instead of deaning up after the fact and focuses on the effectiveness of actions instead of relying on regulatory command and control. A public health approach evaluates the adverse health effects experienced by a population, identifies possible causes of those effects, and then seeks to determine the relative contribution of each cause to the effects. A public health approach comprises an individual's complete physical and social well-being and includes nondisease end points such as odor and noise. In many cases, the public health foundation of environmental health protection has been obscured by legalistic, technical, centralized decision-making processes that are often unrelated to the problems faced by local communities (3) . The public health basis of our regulatory statutes has been obscured by their reliance on deaning up problems after-thefact instead of preventing them and by their lack of a focus on whole populations. A greater focus on public health principles would better serve the environmental health objectives of our regulatory statutes, although it is the dictates of those very statutes that often pose the greatest impediments to a focus on public health (4-A 
Benzene is in cigarette smoke and in consumer products used at home (9. In fact, the home is the largest source of benzene exposure that we receive, with cigarette smoking contributing 56% of personal exposure and other home activities contributing 21% (s). If the residual leukemia risk from refinery emissions turns out to be significant compared to the leukemia risk contributed by other sources, risk-reduction efforts should focus on further reducing refinery emissions. If the refinery risk proves insignificant by comparison, risk reduction activities might better be directed at other sources. Benzene can also be a precursor to ozone, so in some cases it may make sense to consider its indirect impacts. However, the EPA has always compartmentalized its risk assessment and management approaches. For example, its regulation of marine oil terminals in Valdez, Alaska, where ozone is not an issue, was no different from its regulation of marine oil terminals where ozone is a problem. And while up to 15% methyl tertbutyl ether (MTBE) is required in many places as a gasoline additive, MTBE emissions to air from its manufacturing facilities are tightly controlled because it is considered a hazardous air pollutant.
If residual risks from arsenic and lead emitted by secondary lead smelters are of concern, the context could be multimedia. For example, an EPA study showed that the concentration of airborne arsenic in the vicinity of secondary lead smelters is about 100 times the average concentration of airborne arsenic in the United States. When all sources of exposure to arsenic near smelters are taken into account, however, smelter emissions contribute only about 10% oftotal exposure, raising a broader risk management issue about what action should be taken to reduce arsenic exposure from all sources. Other major sources of arsenic exposure include seafood and cigarette smoke (10) . On the other hand, lead emissions from secondary lead smelters are by far the primary contributor to lead exposure in the vicinity of smelters, despite the many other sources ofhuman exposure to lead (11 
Risk Management Using a Public Health Approach
The overall goal should be to direct risk management resources where they will do the most good to protect or improve the community's health. To achieve that goal, we need to start looking at risks comprehensively. As Daniel Greenbaum, former Commissioner for Environmental Protection for the state of Massachusetts put it in his testimony to the commission (12), I saw far too many cases where extreme attention was placed at an industrial facility on ensuring that every last molecule of a toxic substance was kept out of the air, only to have that same substance ignored as it poured through the floor drain into the groundwater. Taking a look at the whole mix of pollutants, at whole watersheds, is fundamental.
Looking at problems in their contexts should help us start to do that.
The challenge for assessing residual risks in context boils down to understanding how to assess multiple or aggregate risks; making a decision about what to do about a particular source or sources of risk after you have done that is another question altogether. Using a public health approach can help to assess aggregate risks and to target risk management resources by focusing attention on the health effects experienced by a population-not just the individual with the putative highest exposure-and the relative contributions of different pollutant sources or other problems to those effects (4) . A public health approach is a "top-down" approach that starts by focusing on a problem and then seeks to identify what is causing the problem as a guide to determining how best to solve it. In contrast, most of our current Volume 106, Number 9, September 1998 * Environmental Health Perspectives Commentaries * Managing residual risks under the Clean Air Act regulatory approaches are "bottom-up"; that is, they start with a cause and then try to eliminate it without determining the extent to which it actually may contribute to a problem. A bottom-up approach makes it difficult to set priorities among risks or to evaluate whether a risk management action has had an impact on a public health problem. Advances in molecular biology have moved us closer to linking biomarkers of effects with biomarkers of exposure, making a top-down approach more feasible by facilitating attribution of causality. In the meantime, public health approach implementation should target diseases with recognized environmental components, such as asthma or lung cancer. Diseases with less well-understood environmental components will require better-developed monitoring and surveillance systems and better understanding of the interplay of causative factors before a public health approach can be applied effectively. An intermediate step toward achieving that goal will be to replace mathematically modeled estimates of exposure with biological measures of actual exposure. Ideally, biological markers that reflect both exposure and effect will provide the linkage central to an effective public health approach. Carboxyhemoglobin formation is a wellknown example ofa biological marker.
One public health-based approach that has been proposed recently to help manage residual risks is a public health improvement market (13) . A public health improvement market would bring together willing sellers of public health improvements, such as public health departments and community groups, with willing buyers seeking alternatives to further emissions reductions. In this proposal, a limited number of sources meeting current air quality standards would be offered the opportunity to make investments in public health benefits rather than marginal decreases in emissions. Protections would be put in place to avoid individual source backsliding, distributional inequities, adverse health effects, and significant ecological damage. Five elements are envisioned as part of the market approach: * Tradable instruments: a common metric for risk reduction would be developed to allow the valuation ofvarious investments. (14) and broadening concepts of risk characterization (15) are promising signs that the agency is looking beyond its traditional single-chemical, single-medium focus. As it takes on the challenges of assessing residual risks, the agency needs to broaden its focus further to encompass environmental health impacts from the perspective of public health. A nationwide public health surveillance network is needed to facilitate making connections between environmental exposures and public health outcomes. Finally, creative risk management options are needed to optimize the contributions that our limited risk management resources can make towards minimizing residual risks and continuing the environmental and public health improvements we have enjoyed for the last 25 years.
